Outset Medical Inc
$ 4.61
4.77%
17 Apr - close price
- Market Cap 80,571,000 USD
- Current Price $ 4.61
- High / Low $ 4.63 / 4.40
- Stock P/E N/A
- Book Value 6.99
- EPS -5.37
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.15 %
- ROE -1.06 %
- 52 Week High 21.98
- 52 Week Low 3.00
About
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. The company is headquartered in San Jose, California.
Analyst Target Price
$9.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-11 | 2025-11-05 | 2025-08-06 | 2025-05-07 | 2025-02-19 | 2024-11-06 | 2024-08-07 | 2024-05-08 | 2024-02-21 | 2023-11-07 | 2023-08-02 | 2023-05-03 |
| Reported EPS | -0.84 | -0.69 | -0.84 | -3.24 | -5.55 | -5.85 | -0.47 | -0.57 | -0.59 | -0.71 | -0.9 | -0.9 |
| Estimated EPS | -0.24 | -0.65 | -0.98 | -0.94 | -6.19 | -6.32 | -0.45 | -0.55 | -0.61 | -0.67 | -0.78 | -0.74 |
| Surprise | -0.6 | -0.04 | 0.14 | -2.3 | 0.64 | 0.47 | -0.02 | -0.02 | 0.02 | -0.04 | -0.12 | -0.16 |
| Surprise Percentage | -250% | -6.1538% | 14.2857% | -244.6809% | 10.3393% | 7.4367% | -4.4444% | -3.6364% | 3.2787% | -5.9701% | -15.3846% | -21.6216% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -1.04 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OM
2026-04-16 02:09:40
RBC Capital analyst Shagun Singh Chadha maintained a Hold rating on Outset Medical (OM) with a price target of $7.00. The company reported a quarterly revenue of $28.87 million and a GAAP net loss of $19.49 million for the quarter ending December 31. Insider sentiment is negative, with an increase in insider selling over the past quarter.
2026-04-15 02:41:15
RBC Capital has reaffirmed its "Hold" rating for Outset Medical (OM.US) and maintained its target price at $7. Analyst Shagun Singh Chadha, who has a 45.2% success rate, made this assessment. The article includes disclaimers about the nature of the information provided, emphasizing that it is for informational purposes only and not investment advice.
2026-04-10 19:54:40
Outset Medical, Inc. (NASDAQ:OM) has received a consensus "Moderate Buy" rating from five analysts, with an average 12-month price target of $10.00. The stock is currently trading around $4.32, with a market capitalization of $79 million, and saw insider selling activity from its CEO and General Counsel in January. Recent analyst reports show mixed perspectives, with some price target reductions and rating adjustments.
2026-04-09 17:39:34
Outset Medical, Inc. announced equity awards under its Inducement Plan for its newly appointed Executive Vice President of Commercial, Derick Elliott, and one other new non-executive employee. These grants, totaling 96,000 RSUs for Mr. Elliott and 10,380 RSUs for the other employee, were made as a material inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over three years, subject to continued service.
2026-04-09 05:10:00
Outset Medical, Inc. has announced equity awards in the form of restricted stock units (RSUs) for a new Executive Vice President of Commercial, Derick Elliott, and another non-executive employee. These grants, made under Nasdaq Listing Rule 5635(c)(4), are aimed at attracting top talent to drive growth and innovation in its dialysis technology. The RSUs will vest over three years, reinforcing the company's commitment to advancing kidney care.
2026-04-09 05:09:35
Outset Medical, Inc.'s EVP, Commercial, Elliott Derick A., has filed an initial Form 3 insider ownership report. This filing establishes him as a reporting officer but does not indicate any buy, sell, or derivative transactions. The Form 3 confirms his insider status with 0 reported transactions and 0 net buy/sell shares.
